Burkard T, Bloechliger M, Frey N, Huegle T, Layton JB, Jick SS, Meier CR, Spoendlin J. The risk of incident osteoarthritis of the hand in new users of statins: a propensity score-matched sequential cohort study. Presented at the International Society for Pharmacoepidemiology 2017 Mid-Year Meeting; April 3, 2017. London, United Kingdom.
DiBenedetti DB, Zhou X, Reynolds ME, Ogale S, Best J. Assessing methotrexate compliance in rheumatoid arthritis. Presented at the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology; June 2014.
Le Moine JG, Launois R. Mixed treatment comparison, cost-effectiveness analysis and budget impact model in the treatment of rheumatoid arthritis after failure of conventional DMARD therapy using comprehensive Bayesian decision analytical modelling. Presented at the 3rd Joint CES/HESG Workshop; January 11, 2012. Aix-en-Provence, France.
Launois R, Le Moine JG, Huynh MT, Boissier MC. Analyse de l'impact budgétaire de la prise en charge de la polyarthrite rhumatoïde en 1ère, 2ème et 3ème ligne de traitement, après échec d'un traitement de fond. Presented at the French Society of Rheumatology 24th Annual Congress; December 11, 2011. Paris, France.
Launois R, Le Moine JG, Huynh MT, Boissier MC. Efficacité et tolérance des traitements de la polyarthrite rhumatoïde étudiés par méta-analyse hiérarchique bayésienne: combinaison simultanée des résultats relevés dans les essais randomisés et les études observationnelles avec groupe controle. Presented at the French Society of Rheumatology 23rd Annual Congress; November 28, 2010. Paris, France.
Gilsenan AW, Morris LS, Carlson AM. Association between quality of sleep and NSAID use for osteoarthritis in older patients. Presented at the American Society of Consultant Pharmacists National Meeting; 1996. Nashville, TN.